Thalidomide therapy and deep venous thrombosis in multiple myeloma.
Rajkumar
S Vincent
SV
D001241:Aspirin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects*; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000517:prevention & control
D005343:Fibrinolytic Agents; D007166:Immunosuppressive Agents; D013792:Thalidomide; D001241:Aspirin